Tuesday, April 02, 2019 01:44 PM


TUESDAY, April 2, 2019 (HealthDay News) -- Rates of prostate cancer[1] cases and deaths have declined or stabilized in many countries. And the United States had the largest recent decrease in disease incidence, a new study says.

"Previous studies have indicated significant variation in prostate cancer[2] rates, due to factors including detection practices, availability of treatment, and genetic factors," said study author MaryBeth Freeman. She's a senior associate scientist for surveillance research at the American Cancer Society.

"By comparing rates from different countries, we can assess differences in detection practices and improvements in treatment," Freeman said in a news release from the American Association for Cancer Research (AACR).

Researchers examined long-term and short-term data from 44 countries with incidence data and 71 countries with prostate cancer death data.

Of the 44 countries assessed for incidence, prostate cancer rates rose in four countries and fell in seven, with the United States with the biggest decrease. Rates remained stable in the other 33 countries.

Of the 71 countries assessed for prostate cancer death rates, there were decreases ...

News source: WebMD

See also: The Robotic Urologist